LYEL
LYEL
NASDAQ · Biotechnology

Lyell Immunopharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$19.33
-0.73 (-3.64%)
As of May 10, 10:21 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 8 80%
Hold 1 10%
Sell 1 10%
Price Target
Analyst Price Target +44.6% upside
Low Target $18.45
Average Target $27.95
High Target $35.39
Current Price $19.33
Current
$19.33
Target
$27.95
$18.45 $27.95 avg $35.39
Scenario Analysis
Bear Case
$18.45
-4.6%
Low target
Base Case
$27.95
+44.6%
Avg target
Bull Case
$35.39
+83.1%
High target
Risk/Reward
18.3x
Highly favorable
Price in Context
52-Week High
$45.00
-57.0% from high
52-Week Low
$7.65
+152.7% from low
Target vs 52W High
$27.95
-37.9% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-2.33
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%